Mass Drug Administration and beyond: how can we strengthen health systems to deliver complex interventions to eliminate neglected tropical diseases?

MacPherson, Eleanor ORCID: https://orcid.org/0000-0002-7142-1158, Adams, Emily ORCID: https://orcid.org/0000-0002-0816-2835, Bockarie, Moses, Hollingsworth, T Deirdre, Kelly-Hope, Louise ORCID: https://orcid.org/0000-0002-3330-7629, Lehane, Mike, Kovacic, Vanja, Harrison, Robert, Paine, Mark ORCID: https://orcid.org/0000-0003-2061-7713, Reimer, Lisa ORCID: https://orcid.org/0000-0002-9711-4981 and Torr, Steve ORCID: https://orcid.org/0000-0001-9550-4030 (2015) 'Mass Drug Administration and beyond: how can we strengthen health systems to deliver complex interventions to eliminate neglected tropical diseases?'. BMC Proceedings, Vol 9, Issue Suppl 10, S7.

Preview

Text Mass drug administration.pdf - Published Version Available under License Creative Commons Attribution. Download (606kB) | Preview

Abstract

Achieving the 2020 goals for Neglected Tropical Diseases (NTDs) requires scale-up of Mass Drug Administration (MDA) which will require long-term commitment of national and global financing partners, strengthening national capacity and, at the community level, systems to monitor and evaluate activities and impact. For some settings and diseases, MDA is not appropriate and alternative interventions are required. Operational research is necessary to identify how existing MDA networks can deliver this more complex range of interventions equitably. The final stages of the different global programmes to eliminate NTDs require eliminating foci of transmission which are likely to persist in complex and remote rural settings. Operational research is required to identify how current tools and practices might be adapted to locate and eliminate these hard-to-reach foci. Chronic disabilities caused by NTDs will persist after transmission of pathogens ceases. Development and delivery of sustainable services to reduce the NTD-related disability is an urgent public health priority. LSTM and its partners are world leaders in developing and delivering interventions to control vector-borne NTDs and malaria, particularly in hard-to-reach settings in Africa. Our experience, partnerships and research capacity allows us to serve as a hub for developing, supporting, monitoring and evaluating global programmes to eliminate NTDs.

Item Type:	Article
Subjects:	QV Pharmacology > QV 38 Drug action. WA Public Health > Preventive Medicine > WA 110 Prevention and control of communicable diseases. Transmission of infectious diseases WA Public Health > Health Administration and Organization > WA 530 International health administration WC Communicable Diseases > Tropical and Parasitic Diseases > WC 680 Tropical diseases (General)
Faculty: Department:	Biological Sciences > Vector Biology Department Clinical Sciences & International Health > International Public Health Department Biological Sciences > Department of Tropical Disease Biology
Digital Object Identifer (DOI):	https://doi.org/10.1186/1753-6561-9-S10-S7
Depositing User:	Samantha Sheldrake
Date Deposited:	22 Jan 2016 09:25
Last Modified:	09 Sep 2019 08:40
URI:	https://archive.lstmed.ac.uk/id/eprint/5525

Statistics

View details

Actions (login required)

Edit Item